RAGAGLITAZAR
UNII Q5ELR5A7Y5

Substance Identification & Data

This profile provides standardized clinical and technical data for Ragaglitazar, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q5ELR5A7Y5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 222834-30-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q5ELR5A7Y5

CAS Registry Number

222834-30-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RAGAGLITAZAR

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C25H25NO5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WMUIIGVAWPWQAW-XMMPIXPASA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C75192

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

128814

Unique identification number in the NCBI database of chemical substances.

INN ID

8110

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1ccc2Oc3c(N(CCOc4ccc(cc4)C[C@H](C(O)=O)OCC)c2c1)cccc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ragaglitazar. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.